Oncolytic Adenovirus Market Outlook Through 2030 With Analysis Of Industry Trends And Developments

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Growth In Market Value Is Anticipated For The Oncolytic Adenovirus Market Between 2026 And 2030?

The oncolytic adenovirus market has experienced significant growth over recent years. This market is projected to expand from $132.49 billion in 2025 to reach $143.57 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 8.4%. Factors contributing to its historical growth include the emergence of first-generation adenovirus-based therapies, the rising incidence of melanoma and prostate cancer, increased investment in oncolytic virus research, initial uptake by cancer research institutes, and expanding partnerships between biotechnology firms and academic institutions.

The oncolytic adenovirus market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $195.85 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.1%. This projected growth is driven by factors such as an escalating demand for engineered adenovirus therapies, their expanding use in treating breast, ovarian, and lung cancers, increased involvement from biotechnology firms, heightened investment in clinical trials and research and development (R&D), and the broadening capabilities of hospitals and research institutes in gene therapy. Key trends foreseen during this period encompass the growing integration of AI and big data in oncolytic virus research, the expanding application of genomics and precision medicine in virus engineering, a wider embrace of digital platforms for overseeing clinical trials, enhanced automation in the production and quality control of viruses, and the proliferation of IoT-enabled systems for monitoring virus storage and distribution.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21235&type=smp

What Major Growth Factors Are Impacting The Oncolytic Adenovirus Market?

The escalating prevalence of cancer is anticipated to fuel the expansion of the oncolytic adenovirus market. Cancer, a condition marked by uncontrolled cellular multiplication and metastasis throughout the body, is seeing an uptick in its occurrence due to factors such as an aging global populace, various lifestyle choices, environmental exposures, inherited predispositions, and advancements in diagnostic methods. Oncolytic adenoviruses offer a promising therapeutic avenue by specifically targeting and eradicating cancerous cells. Supporting this trend, reports from the National Cancer Institute (NCI), a US-based government agency, indicated nearly 20 million new cancer cases and 9.7 million deaths globally in May 2024, with forecasts for 2040 suggesting an increase to 29.9 million cases and 15.3 million deaths. Additionally, data from 2023 by the Australian Bureau of Statistics, an Australia-based government agency, revealed that 1.8% of Australians lived with cancer, with a higher proportion among males (2.1%) compared to females (1.6%), particularly those aged 75 and over. Consequently, the rising incidence of cancer is a key driver for the growth of the oncolytic adenovirus market.

How Are Different Segment Groups Identified Within The Oncolytic Adenovirus Market?

The oncolytic adenovirus market covered in this report is segmented –

1) By Virus Type: Adenovirus Type 5-Based Oncolytic Viruses, Adenovirus Type 2-Based Oncolytic Viruses, Other Virus Types

2) By Application: Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Other Applications

3) By End-User: Hospitals, Cancer Research Institutes, Biotechnology Companies, Academic And Research Institutes

Subsegments:

1) By Adenovirus Type 5-Based Oncolytic Viruses: First-Generation Adenovirus Type 5-Based, Second-Generation Adenovirus Type 5-Based, Engineered Adenovirus Type 5-Based

2) By Adenovirus Type 2-Based Oncolytic Viruses: First-Generation Adenovirus Type 2-Based, Second-Generation Adenovirus Type 2-Based, Engineered Adenovirus Type 2-Based

3) By Other Virus Types: Modified Adenovirus Strains, Hybrid Adenovirus Types, Chimeric Adenoviruses

Which Trends Are Shaping The Oncolytic Adenovirus Market Landscape?

Leading companies in the oncology nutrition market are focused on creating innovative solutions, such as specialized nutrition for cancer patients, to improve treatment outcomes, support immune function, manage treatment-related side effects, and enhance the overall quality of life during and after cancer therapy. Nutrition for cancer patients involves specialized dietary plans and nutritional interventions designed to meet the unique needs of individuals undergoing cancer treatment. For example, in June 2024, AEACAP, the Spain-based Patients Support Association, introduced a new nutrition series intended to support cancer patients and their caregivers. This initiative features a collection of videos released every two weeks, presented by a specialized nutritionist, aiming to provide essential information on diet and nutrition during and after cancer treatment, thereby highlighting the critical role that proper nutrition plays in enhancing treatment outcomes and overall quality of life for those affected by cancer.

Who Are The Prominent Players Across The Oncolytic Adenovirus Market?

Major companies operating in the oncolytic adenovirus market are Amgen Inc., Targovax ASA, CG Oncology Inc., Replimune Group Inc., Imugene Limited, Oncorus Inc., PsiOxus Therapeutics Ltd., Vyriad Inc., Transgene SA, Valo Therapeutics Oy, EpicentRx Inc., DNAtrix Inc., Shanghai Sunway Biotech Co. Ltd., TILT Biotherapeutics Ltd., Oncolys BioPharma Inc., Lokon Pharma AB, GeneMedicine Co. Ltd., Akamis Bio Ltd., Genelux Corporation, SillaJen Inc.

Access The Complete Oncolytic Adenovirus Market Report:

https://www.thebusinessresearchcompany.com/report/oncolytic-adenovirus-global-market-report

What Is The Largest Regional Market In The Oncolytic Adenovirus Market?

North America was the largest region in the oncolytic adenovirus market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic adenovirus market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Oncolytic Adenovirus Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21235&type=smp

Browse Through More Reports Similar to the Global Oncolytic Adenovirus Market 2026, By The Business Research Company

Companion Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-diagnostics-global-market-report

Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Clinical Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795